{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:49:35Z","timestamp":1791265775892,"version":"4.1.0"},"reference-count":16,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2016.00800","type":"journal-article","created":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T19:17:02Z","timestamp":1464808622000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":107,"title":["Clinical Features of Severe or Fatal Mycoplasma pneumoniae Pneumonia"],"prefix":"10.3389","volume":"7","author":[{"given":"Koichi","family":"Izumikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,6,1]]},"reference":[{"key":"B1","first-page":"133","article-title":"Fulminant Mycoplasma pneumoniae pneumonia.","volume":"162","author":"Chan","year":"1995","journal-title":"West. J. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2249.1994.tb05502.x","article-title":"Intranasal inoculation of Mycoplasma pulmonis in mice with severe combined immunodeficiency (SCID) causes a wasting disease with grave arthritis.","volume":"98","author":"Evengard","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"B3","author":"Fernald","year":"1981","journal-title":"Immunology of Mycoplasma Infection."},{"key":"B4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10156-004-0351-1","article-title":"A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology.","volume":"10","author":"Ishida","year":"2004","journal-title":"J. Infect. Chemother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jiac.2013.09.009","article-title":"Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: a review of the Japanese literature.","volume":"20","author":"Izumikawa","year":"2014","journal-title":"J. Infect. Chemother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.4187\/respcare.03920","article-title":"Lactate dehydrogenase as a biomarker for prediction of refractory Mycoplasma pneumoniae pneumonia in children.","volume":"60","author":"Lu","year":"2015","journal-title":"Respir. Care"},{"key":"B7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1099\/jmm.0.45920-0","article-title":"Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study.","volume":"54","author":"Miyashita","year":"2005","journal-title":"J. Med. Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jiac.2014.10.008","article-title":"Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adults.","volume":"21","author":"Miyashita","year":"2015","journal-title":"J. Infect. Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2169\/internalmedicine.45.1691","article-title":"The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations.","volume":"45","author":"Miyashita","year":"2006","journal-title":"Intern. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1099\/jmm.0.47119-0","article-title":"Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit.","volume":"56","author":"Miyashita","year":"2007","journal-title":"J. Med. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4168\/aair.2012.4.1.55","article-title":"Fulminant and fatal multiple organ failure in a 12-year-old boy with Mycoplasma pneumoniae infection.","volume":"4","author":"Park","year":"2012","journal-title":"Allergy Asthma Immunol. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/intimm\/13.7.933","article-title":"Discrimination of bacterial lipoproteins by Toll-like receptor 6.","volume":"13","author":"Takeuchi","year":"2001","journal-title":"Int. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2169\/internalmedicine.40.345","article-title":"Fulminant Mycoplasma pneumoniae pneumonia.","volume":"40","author":"Takiguchi","year":"2001","journal-title":"Intern. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1378\/chest.121.5.1493","article-title":"Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults.","volume":"121","author":"Tanaka","year":"2002","journal-title":"Chest"},{"key":"B15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2169\/internalmedicine.41.229","article-title":"Corticosteroid therapy for hemolytic anemia and respiratory failure due to Mycoplasma pneumoniae pneumonia.","volume":"41","author":"Tsuruta","year":"2002","journal-title":"Intern. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1128\/CMR.17.4.697-728.2004","article-title":"Mycoplasma pneumoniae and its role as a human pathogen.","volume":"17","author":"Waites","year":"2004","journal-title":"Clin. Microbiol. Rev."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T19:17:02Z","timestamp":1464808622000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2016.00800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":16,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2016.00800","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,1]]}}}